New Drug Approvals news from FierceHealthcare
Press Releases
CorMedix Appoints Mark A. Klausner, M.D. as Chief Medical Officer
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and Read more >>
Akorn Announces the Sale of the Akorn-Strides Joint Venture Product Portfolio to Pfizer, Inc.
LAKE FOREST, Ill.--(BUSINESS WIRE)-- Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement Read more >>
